米尔韦图西马布索拉夫坦辛:作用机制,临床和翻译科学
Rajeev Menon1, Emarjola Bako2, Shuhan Liu1
1Clinical Pharmacology, AbbVie Inc., North Chicago, Illinois, USA.
Clinical and translational science
|January 16, 2026
概括
米尔韦图西马布索拉夫坦辛 (MIRV) 是一种抗体-药物结合物,有效对抗具有高叶酸受体α (FRα) 表达的抗性卵巢癌 (PROC). 在MIRASOL试验中证明了MIRV.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 表皮卵巢癌 (EOC) 经常过度表达叶酸受体α (FRα),使其成为治疗的有吸引力的标.
- 抗性卵巢癌 (PROC) 的治疗选择有限,预后不佳,平均存活时间为12-14个月.
- Mirvetuximab soravtansine (MIRV) 是一种针对FRα的抗体-药物结合体,于2022年批准用于FRα阳性PROC.
研究的目的:
- 要审查mirvetuximab soravtansine (MIRV) 的作用机制,药理动力学,药理动力学和临床数据.
- 突出MIRV在患有白金耐药卵巢癌 (PROC) 和高FRα表达的患者的疗效和安全性.
主要方法:
- 对mirvetuximab soravtansine (MIRV) 的临床前和临床数据的审查.
- 分析了MIRASOL第三期试验的结果,将MIRV与FRα阳性PROC中的化疗进行了比较.
- 对客观反应率 (ORR),无进展生存率 (PFS) 和整体生存率 (OS) 的评估.
主要成果:
- 与化疗相比,MIRV在高FRα表达的PROC中显示出更高的疗效.
- 米拉索尔试验显示,MIRV实现了42%的ORR与化疗16%相比,PFS的中位数为5.6与4.0个月,中位数的OS为16.5与12.8个月.
- 在PROC中审查了MIRV的关键临床疗效和安全数据.
结论:
- 米尔韦图西马布索拉夫坦辛 (MIRV) 为FRα阳性抗性卵巢癌 (PROC) 患者提供了显著的治疗进展.
- 米拉索尔试验证实了米尔维对标准化疗的优越性,改善了反应率和生存结果.
- 对于一个患者群体来说,MIRV代表了一个关键的新选择,其治疗选择历来有限.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Mechanisms of Retrovirus-induced Cancers
6.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Microorganisms in Medicine and Therapeutics
987
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
987


